SCHEMBL24853994

SCHEMBL24853994

CC(C)(C)OC1CN(CC(F)(F)F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24854210 0.81 — —
SCHEMBL17471307 0.80 GPR119 (0.39) —
SCHEMBL21227513 0.78 GRIN1 (0.30) —
SCHEMBL12395684 0.76 — —
SCHEMBL22252305 0.75 PDK2 (0.31) —
SCHEMBL19964610 0.75 HTR4 (0.30) —
SCHEMBL20687918 0.73 — —
SCHEMBL20689390 0.73 ARG1 (0.30) —
SCHEMBL26972518 0.72 GBA1 (0.36) —
SCHEMBL26151533 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002382-A1 SPIRO RING-CONTAINING QUINAZOLINE COMPOUNDS Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2023-01-05 — — US disclosed
Send feedback